Astera Labs, Inc. $ALAB Shares Purchased by Stephens Investment Management Group LLC

Stephens Investment Management Group LLC raised its stake in Astera Labs, Inc. (NASDAQ:ALAB) by 13.0% in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 269,885 shares of the company’s stock after acquiring an additional 31,108 shares during the quarter. Stephens Investment Management Group LLC’s holdings in Astera Labs were worth $29,579,000 at the end of the most recent quarter.

Other institutional investors also recently made changes to their positions in the company. Praxis Investment Management Inc. boosted its stake in shares of Astera Labs by 7.0% during the first quarter. Praxis Investment Management Inc. now owns 4,183 shares of the company’s stock valued at $458,000 after acquiring an additional 272 shares during the last quarter. V Square Quantitative Management LLC acquired a new position in Astera Labs in the 1st quarter valued at about $93,000. QRG Capital Management Inc. raised its stake in Astera Labs by 18.0% in the 1st quarter. QRG Capital Management Inc. now owns 4,394 shares of the company’s stock valued at $482,000 after purchasing an additional 669 shares during the last quarter. Tensor Edge Capital LLC lifted its holdings in Astera Labs by 246.1% in the 1st quarter. Tensor Edge Capital LLC now owns 228,400 shares of the company’s stock valued at $25,033,000 after purchasing an additional 162,400 shares in the last quarter. Finally, Counterpoint Mutual Funds LLC purchased a new position in Astera Labs in the 1st quarter valued at about $4,723,000. 60.47% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In other Astera Labs news, Director Jack R. Lazar sold 10,000 shares of the company’s stock in a transaction dated Thursday, June 4th. The stock was sold at an average price of $355.17, for a total transaction of $3,551,700.00. Following the completion of the sale, the director directly owned 75,688 shares in the company, valued at $26,882,106.96. This represents a 11.67% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, COO Sanjay Gajendra sold 400,000 shares of the company’s stock in a transaction dated Thursday, May 21st. The stock was sold at an average price of $290.30, for a total value of $116,120,000.00. Following the sale, the chief operating officer owned 5,064,213 shares of the company’s stock, valued at $1,470,141,033.90. This represents a 7.32% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 1,981,441 shares of company stock valued at $444,969,514 in the last 90 days. 10.40% of the stock is owned by corporate insiders.

Astera Labs Price Performance

Shares of ALAB opened at $406.42 on Friday. The firm has a market cap of $69.66 billion, a PE ratio of 274.61, a price-to-earnings-growth ratio of 4.66 and a beta of 3.66. The company’s fifty day moving average is $314.72 and its two-hundred day moving average is $205.55. Astera Labs, Inc. has a fifty-two week low of $88.18 and a fifty-two week high of $499.48.

Astera Labs (NASDAQ:ALAB) last released its quarterly earnings data on Tuesday, May 5th. The company reported $0.61 EPS for the quarter, topping analysts’ consensus estimates of $0.54 by $0.07. The business had revenue of $308.36 million during the quarter, compared to the consensus estimate of $292.19 million. Astera Labs had a return on equity of 18.49% and a net margin of 26.72%.The business’s revenue for the quarter was up 93.5% on a year-over-year basis. During the same period in the prior year, the firm posted $0.33 EPS. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. As a group, equities research analysts anticipate that Astera Labs, Inc. will post 1.84 earnings per share for the current year.

Analysts Set New Price Targets

ALAB has been the topic of several analyst reports. Rothschild & Co Redburn assumed coverage on shares of Astera Labs in a research note on Friday, May 1st. They set a “neutral” rating and a $153.00 price target on the stock. Northland Securities lowered shares of Astera Labs from an “outperform” rating to a “market perform” rating in a research report on Tuesday, May 26th. UBS Group upped their price objective on shares of Astera Labs from $205.00 to $400.00 and gave the company a “neutral” rating in a research note on Monday, June 29th. Evercore restated an “outperform” rating and set a $297.00 target price on shares of Astera Labs in a research report on Tuesday, May 19th. Finally, Royal Bank Of Canada lifted their target price on shares of Astera Labs from $250.00 to $270.00 and gave the stock an “outperform” rating in a research note on Wednesday, May 6th. Twelve research analysts have rated the stock with a Buy rating and eleven have issued a Hold rating to the company’s stock. According to MarketBeat, Astera Labs presently has a consensus rating of “Moderate Buy” and a consensus target price of $265.75.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.